PuSH - Publikationsserver des Helmholtz Zentrums München

Cardiac proteostasis in obesity and cardiovascular disease.

Kardiale Proteostase bei Adipositas und kardiovaskulären Erkrankungen.

Herz 49, 118-123 (2024)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Cardiovascular diseases (CVD) are closely linked to protein homeostasis (proteostasis) and its failure. Beside genetic mutations that impair cardiac protein quality control, obesity is a strong risk factor for heart disease. In obesity, adipose tissue becomes dysfunctional and impacts heart function and CVD progression by releasing cytokines that contribute to systemic insulin resistance and cardiovascular dysfunction. In addition, chronic inflammation and lipotoxicity compromise endoplasmic reticulum (ER) function, eliciting stress responses that overwhelm protein quality control beyond its capacity. Impairment of proteostasis-including dysfunction of the ubiquitin-proteasome system (UPS), autophagy, and the depletion of chaperones-is intricately linked to cardiomyocyte dysfunction. Interventions targeting UPS and autophagy pathways are new potential strategies for re-establishing protein homeostasis and improving heart function. Additionally, lifestyle modifications such as dietary interventions and exercise have been shown to promote cardiac proteostasis and overall metabolic health. The pursuit of future research dedicated to proteostasis and protein quality control represents a pioneering approach for enhancing cardiac health and addressing the complexities of obesity-related cardiac dysfunction.
Impact Factor
Scopus SNIP
Altmetric
1.100
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Adipose Tissue ; Autophagy ; Endoplasmic Reticulum ; Heart Diseases ; Proteasome; Adipose-tissue; Nrf1; Cardiomyopathy; Enhancement; Inhibitor
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 0340-9937
e-ISSN 1615-6692
Zeitschrift Herz
Quellenangaben Band: 49, Heft: 2, Seiten: 118-123 Artikelnummer: , Supplement: ,
Verlag Springer
Verlagsort München
Begutachtungsstatus Peer reviewed
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-501900-251
G-501900-250
Förderungen European Research Training Group (ERC) Starting Grant PROTEOFIT
Deutsches Zentrum fur Herz-Kreislauf-Forschung (DZHK)
DFG
Scopus ID 85184420927
PubMed ID 38329532
Erfassungsdatum 2024-04-19